| Non-contrast 1.5 T WHCA (N = 20 studies) | Contrast-enhanced 3.0 T WHCA (N = 9 studies) | P-value |
---|---|---|---|
Patient-based analysis | |||
 Sensitivity | 0.86 (0.80–0.90) | 0.92 (0.87–0.96) | 0.07 |
 Specificity | 0.74 (0.64–0.82) | 0.87 (0.80–0.92) | 0.02 |
 AUC | 0.88 | 0.94 | N/A |
Vessel-based analysis | |||
 Sensitivity | 0.84 (0.77–0.90) | 0.91 (0.86–0.94) | 0.07 |
 Specificity | 0.86 (0.77–0.92) | 0.91 (0.89–0.93) | 0.20 |
 AUC | 0.91 | 0.95 | N/A |
Segment-based analysis | |||
 Sensitivity | 0.82 (0.75–0.88) | 0.88 (0.85–0.91) | 0.1 |
 Specificity | 0.93 (0.88–0.95) | 0.95 (0.94–0.96) | 0.28 |
 AUC | 0.93 | 0.95 | N/A |